Source: Global Legal Chronicle

Kelso: Kelso & Company's Investment in Valenz

Debevoise & Plimpton LLP has advised Kelso & Company in the transaction. Kelso & Company executed its investment in Valenz® Health ("Valenz"). Kelso & Company is one [...]

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Frank Loverro's photo - Co-CEO of Kelso

Co-CEO

Frank Loverro

CEO Approval Rating

90/100

Read more